Chiome Bioscience Inc. [4583.T]
TOKYO, May 11 (Pulse News Wire) – Chiome Bioscience Inc. (4583.T) completed the subscription process for restricted share awards.
The issuance was approved during the company's board meeting held on April 14, 2026. Under the agreement, Chiome Bioscience issued ordinary shares totaling 199,900.
Each share was subscribed at ¥102 per share, resulting in a total issuance amount of ¥20.4 million. The restricted shares were allocated to three directors, excluding audit committee members and outside directors.
🟢 Confidence: High AI-translated content.